VIA
ASXC

Vantage Investment Advisors’s Asensus Surgical, Inc. ASXC Stock Holding History

Vantage Investment Advisors’s Portfolio ASXC Stock Details ASXC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-17
Closed – – 871
2017
Q4 		$0 Buy
+17
New +$523 ﹤0.01% 859

Other funds holding ASXC

AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
SHI
SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MCM
Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return
SG
StepStone Group La Jolla, California $207M AUM 12.33% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Vantage Investment Advisors's ASXC Position: Q1 2018 in Review

Vantage Investment Advisors sold out of Asensus Surgical, Inc. (ASXC) in Q1 2018, closing a stake of 17 shares.

Vantage Investment Advisors first reported a position in ASXC in Q4 2017 and held it in 1 quarter. The position peaked at $0 in Q4 2017. 95 funds tracked by Wall St. Rank hold ASXC as of Q1 2018.

  • Vantage Investment Advisors reported no remaining Asensus Surgical, Inc. position as of Q1 2018 after selling out during the quarter.
  • Vantage Investment Advisors sold 17 Asensus Surgical, Inc. shares in Q1 2018.
  • Vantage Investment Advisors first reported a position in Asensus Surgical, Inc. in Q4 2017 and held it in 1 quarter.
  • Vantage Investment Advisors's Asensus Surgical, Inc. position peaked at $0 in Q4 2017.
  • 95 funds tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q1 2018.

Based on Vantage Investment Advisors's 13F filing for Q1 2018, filed 10 May 2018.